✦ LIBER ✦

Association of Molecular Markers With Toxicity Outcomes in a Randomized Trial of Chemotherapy for Advanced Colorectal Cancer: The FOCUS Trial

✍ Scribed by Braun, M. S.; Richman, S. D.; Thompson, L.; Daly, C. L.; Meade, A. M.; Adlard, J. W.; Allan, J. M.; Parmar, M. K.B.; Quirke, P.; Seymour, M. T.

Book ID: 127049060
Publisher: American Society of Clinical Oncology
Year: 2009
Tongue: English
Weight: 192 KB
Volume: 27
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2008.21.6283

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Different strategies of sequential and c

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial

✍ Matthew T Seymour; Timothy S Maughan; Jonathan A Ledermann; Clare Topham; Roger 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 201 KB

Quality of life versus prolongation of l

Quality of life versus prolongation of life in patients treated with chemotherapy in advanced colorectal cancer: A review of randomized controlled clinical trials

✍ Susanne Joëlle de Kort; Pax H.B. Willemse; Jolanda M. Habraken; Hanneke C.J.M. d 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 160 KB

PP56. A model of patients' preferences f

PP56. A model of patients' preferences for chemotherapy outcomes in advanced colorectal cancer: Do gains in survival justify the toxicity?

✍ C Schmitt; B Henry-Launois; B Jolain; MC Cavallo; L Mantovani 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 324 KB

A randomized trial of anemia correction

A randomized trial of anemia correction with two different hemoglobin targets in the first-line chemotherapy of advanced gastric cancer

✍ Se Hoon Park; Eunmi Nam; Soo-Mee Bang; Eun Kyung Cho; Dong Bok Shin; Jae Hoon Le 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 315 KB

Chemotherapy vs. chemoimmunotherapy with

Chemotherapy vs. chemoimmunotherapy with methanol extraction residue of bacillus calmette-guerin (MER) in advanced breast cancer: A randomized trial by the piedmont oncology association

✍ Hyman B. Muss; Frederick Richards II; M. Robert Cooper; Douglas R. White; Don V. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 597 KB

Effects of the addition of MER, a nonspecific, nonviable immunostimulant, to two combination chemotherapy programs were explored in patients with metastatic breast cancer. Patients were randomized to either CDVFP [cyclophosphamide (C), doxorubicin (D), vincristine (V), fluorouracil (F) and prednison

Randomized Phase III Trial Exploring the

Randomized Phase III Trial Exploring the Use of Long-Acting Release Octreotide in the Prevention of Chemotherapy-Induced Diarrhea in Patients With Colorectal Cancer: The LARCID Trial

✍ Hoff, P. M.; Saragiotto, D. F.; Barrios, C. H.; del Giglio, A.; Coutinho, A. K.; 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 199 KB